Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
A congressman whose district includes the UCLA hospital where more than 100 patients were exposed to a drug-resistant superbug is calling for the House Committee on Oversight and Government Reform to hold the Food and Drug Administration (FDA) accountable for not taking action sooner when it learned that certain medical devices could spread the dangerous bacteria from patient to patient. Rep. Ted Lieu, D-Calif., who also serves on the House Committee on Oversight and Government Reform, urged his fellow committee members to hold a hearing on the matter, adding that the agency’s recent safety alert failed to adequately provide health care ... Read More
The Food and Drug Administration (FDA) has issued an extensive report on how the agency aims to modernize is surveillance of medical devices to help ensure patient safety and increase manufacturer liability. The report comes in the wake of litigation over injuries caused by faulty medical devices from metal-on-metal hip implants to transvaginal mesh. The report, commissioned by the FDA and prepared by an expert panel of representatives from agencies, organizations and corporations, involves the implementation of the agency’s new unique device identifiers, or UDIs. The system is intended to assign a unique identifier to medical devices by the year ... Read More
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to add up to $350 million to a $2.5 billion settlement involving its defective hip implants. The original settlement, penned in November 2013, awarded up to $250,000 to about 8,000 patients who had undergone revision surgery to have their ASR hip replacement system removed prior to Sept. 1, 2013. Patients received less than the full $250,000 based on factors such as if they smoked or had a high body mass index. The original settlement also included $475 million in supplemental awards for patients who suffered further injuries from the revision surgery. About ... Read More
One person has died in a North Carolina hospital after becoming infected with the same superbug bacteria blamed for two recent deaths in Los Angeles. According to the Carolinas HealthCare System in Charlotte, N.C., 15 patients admitted to the hospital carried carbapenem-resistant Enterobacteriaceae (CRE) upon admission. Three patients contracted a CRE infection in the hospital, and one of the patients died. The North Carolina hospital has not said how three of its patients contracted the infection, and it is not yet clear whether the reported death was caused by a CRE infection. The CRE bacteria are from a family of ... Read More
Two lots of the injectable muscle relaxer atracurium besylate manufactured by Emcure Pharmaceuticals and distributed by Sagent Pharmaceuticals are being recalled because the Food and Drug Administration (FDA) has observed activities during manufacturing that put into question the drug’s sterility. Non-sterility of a drug administered intravenously can result in infections, which could be fatal, especially in patients with compromised immune systems. Atracurium besylate is used along with anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. The drug is listed on the World Health Organization’s List of Essential Medicines, a list of the most important ... Read More
Johnson & Johnson subsidiary Janssen Pharmaceutical was ordered to pay $2.5 million in damages to the parents of an autistic boy who claimed the drug company covered up risks associated with its antipsychotic drug Risperdal, leading their son to grow female breasts, a condition known as gynecomastia. The lawsuit was filed by the family of Austin Pledger, now 20. They claimed their son took Risperdal for five years beginning at age 7, during which he developed gynecomastia. At the time, Risperdal was not approved to treat children but the drug company actively promoted the drug to physicians for pediatric use. Doctors can prescribe ... Read More
A Texas man has filed a lawsuit against the makers of the antipsychotic drug Risperdal claiming he suffered long-term emotional problems after the drug caused him to grow female breasts. Jacoby Moore filed his Risperdal lawsuit in Jefferon County District Court against Ortho-McNeil-Janssen Pharmaceuticals Inc., formerly known as Janssen Pharmaceuticals Inc., Johnson & Johnson Company, Johnson & Johnson Research and Development, and Dr. Ravikumar Kanneganti both individually and doing business as Child Guidance Center. Moore says he was prescribed Risperdal by Kanneganti when he was 7 to treat attention deficit disorder (ADHD). Risperdal, known generically as risperidone, is approved to ... Read More
Some specialized surgical tools used to diagnose and treat various medical conditions can sicken and even worsen the odds of survival in some patients, according to Food and Drug Administration (FDA) Safety Alerts issued in recent months. Patients undergoing procedures with these surgical tools are advised to discuss with their doctors the risks and benefits of using these devices, and whether proper measures are being taken to ensure their safety. Duodenoscopes – These specialized endoscopes have flexible parts that are fed down a patient’s throat to treat gallstones, cancers and other digestive system problems. More than 500,000 duodenoscope procedures are ... Read More
A California teenager is in “grave condition” with an antibiotic resistant superbug infection months after undergoing an endoscopic procedure at Ronald Reagan UCLA Medical Center in Los Angeles, stoking fears that the design of specialized duodenoscopes used on about a half a million patients a year makes them difficult to thoroughly sanitize. Duodenoscopes are flexible fiber-optic tubes fitted with a light and camera that that are inserted down the throat, enabling physicians to examine an organ. Regulators and medical professionals are now learning the devices are can be extremely difficult to disinfect, a potential design flaw that could open the ... Read More
An English woman is suing the manufacturer of her metal-on-metal hip replacement system claiming the implant poisoned her and left her disabled. In 2007, Jane Webb, who suffered from osteo-arthritis, had surgery known as hip resurfacing, a type of operation generally offered to younger patients as an alternative to full joint replacement. The implant was expected to last 15 to 20 years. However, in September 2003, doctors discovered high levels of metal in her blood – a type of blood poisoning known as metallosis. Her hip implant was failing, corroding right inside her body. Doctors performed surgery to remove and ... Read More